A Historic First: Beike Biotechnology receives FDA drug master file recognition for Stem Cell Therapy
For the millions of people living with chronic and autoimmune conditions, the promise of stem cell therapy has long offered hope. Today, that hope takes a significant step closer to reality. Beike Biotechnology has announced that its Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) have been granted a Type II Drug Master File (DMF) filing … Read more
